4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001599298-23-000103
Chief Executive Officer bought 5,000 shares at $2.07 ($10,350)
- Chief Executive Officer acquired 805,495 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Zanganeh Mahkam · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-11 | Option exercise : show line 1 in the form | +489,814 | $1.44 | $705,332 | 489,814 | D |
| 2023-12-12 | Purchase : show line 2 in the form | +5,000 | $2.07 | $10,350 | 494,814 | D |
| 2023-12-11 | Option exercise : show line 3 in the form | +315,681 | $1.58 | $498,776 | 24,889,479 | I |
| Open-market purchases · 5,000 sh · avg $2.07 · $10,350 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-11 | Option exercise : show line 4 in the form Warrant (right to buy) | −489,814 | 0 | D |
| 2023-12-11 | Option exercise : show line 5 in the form Warrant (right to buy) | −315,681 | 0 | I |
Loading xslF345X05/wk-form4_1702505507.xml…